Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the effect of the addition of idelalisib (formerly GS-1101) to rituximab on progression-free survival (PFS) in subjects with previously treated chronic lymphocytic leukemia (CLL).
Inclusion criteria
- Chronic lymphocytic leukemia (CLL)